NCT02732197

Brief Summary

Background: This study was designed to investigate the effect of sedation on the occurrence of maternal hypotension in preoperatively anxious parturients undergoing urgent category-1 Cesarean section (C/S) under spinal anesthesia. Methods: After institutional ethics committee approval, prospectively collected data of 1824 parturients undergoing C/S were reviewed. Parturients with high preoperative anxiety scores (visual analogue scale for anxiety (VAS-A)≥70) undergoing C/S under spinal anesthesia with thiopental (Group S=49) and without any other type of sedation (Group NS=53) were included in the analysis. Hemodynamic parameters were documented and maximum systolic arterial pressure (SAP) reductions from the baseline after spinal anesthesia were calculated. Incidences of hypotension (SAP≥30% decrease from baseline or \<100 mmHg) and bradycardia (HR\<55 beats/min), and related-ephedrine and -atropine requirements were noted. Our primary endpoint was to compare the maximum SAP reductions from the baseline values in Groups S and NS. Secondary endpoints were incidences of hypotension and bradycardia, required ephedrine and atropine doses, newborn Apgar scores at 1st and 5th min.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 4, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 8, 2016

Completed
Last Updated

April 11, 2016

Status Verified

April 1, 2016

Enrollment Period

6 months

First QC Date

April 4, 2016

Last Update Submit

April 8, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Maximum systolic arterial pressure (SAP) reductions from the baseline values

    % SAP reduction after spinal anesthesia

    0-10 minutes

Secondary Outcomes (8)

  • Incidence of maternal hypotension

    0-30 minutes

  • Incidence of maternal bradycardia

    0-30 minutes

  • Ephedrine requirement

    0-30 minutes

  • Atropine requirement

    0-30 minutes

  • Incidence of maternal nausea

    0-30 minutes

  • +3 more secondary outcomes

Study Arms (2)

Sedation (S)

Parturients who received IV thiopental 2 mg kg-1 and if necessary additional 50 mg immediately after spinal anesthesia until reaching at least Ramsay sedation score of 3 (1: patient anxious, agitated or restless, 6: patient with no response to light glabella tap or loud auditory stimulus.).

Drug: Sedation

No sedation (NS)

Parturients who did not receive any sedative agent after the spinal anesthesia performance.

Drug: No sedation

Interventions

Parturients who received IV thiopental 2 mg kg-1 and if necessary additional 50 mg immediately after spinal anesthesia until reaching at least Ramsay sedation score of 3 (1: patient anxious, agitated or restless, 6: patient with no response to light glabella tap or loud auditory stimulus.).

Also known as: Thiopental
Sedation (S)

Parturients did not receive any type of sedation after spinal anesthesia.

Also known as: No drug
No sedation (NS)

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Parturients undergoing urgent category-1 Cesarean section (C/S) under spinal anesthesia

You may qualify if:

  • Urgent category-1 C/S
  • ASA physical status I-II
  • Aged between 18 and 35 years
  • Term (≥37 weeks) singleton pregnancy
  • BMI \<40 kg/m2
  • Height \>150 cm or \<180 cm
  • High preoperative anxiety scores (visual analogue scale for anxiety (VAS-A) ≥70)
  • Spinal anesthesia with thiopental sodium sedation
  • Spinal anesthesia without any sedation

You may not qualify if:

  • Preoperative prehydration
  • Placenta previa
  • Placenta accreta
  • Hypertension
  • Pregnancy-induced hypertension
  • Urgent category ≥2
  • General anesthesia
  • Spinal anesthesia with sedation other than thiopental sodium

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Van Training and Research Hospital, Department of Anesthesiology

Van, Turkey (Türkiye)

Location

Related Publications (1)

  • Orbach-Zinger S, Ginosar Y, Elliston J, Fadon C, Abu-Lil M, Raz A, Goshen-Gottstein Y, Eidelman LA. Influence of preoperative anxiety on hypotension after spinal anaesthesia in women undergoing Caesarean delivery. Br J Anaesth. 2012 Dec;109(6):943-9. doi: 10.1093/bja/aes313. Epub 2012 Sep 10.

MeSH Terms

Interventions

Thiopental

Intervention Hierarchy (Ancestors)

ThiobarbituratesBarbituratesPyrimidinonesPyrimidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Cenk Sahan, MD

    Design and conduct the study, review and analyze the data, and write the manuscript

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Anesthesiologist

Study Record Dates

First Submitted

April 4, 2016

First Posted

April 8, 2016

Study Start

August 1, 2014

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

April 11, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will not share

Locations